Strategy Asset Managers Llc
Source: SEC Form 13F · as of Mar 2026Strategy Asset Managers Llc holds 16 biotech & pharma companies tracked by BioSniper, totaling $56.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$56.9M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 19,781 | $18.2M |
| JNJJOHNSON & JOHNSON | 74,073 | $18.1M |
| PMPhilip Morris International Inc | 47,323 | $7.8M |
| MRKMerck & Co., Inc. | 35,910 | $4.3M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 3,164 | $1.4M |
| CAHCardinal Health Inc. | 6,100 | $1.3M |
| CORCencora Inc. | 3,806 | $1.2M |
| AMGNAMGEN INC | 3,008 | $1.1M |
| GMOptec International, Inc. | 10,062 | $750K |
| MCKMcKesson Corporation | 844 | $730K |
| ABBVAbbVie Inc. | 2,271 | $494K |
| ABTABBOTT LABORATORIES | 3,908 | $401K |
| ZTSZoetis Inc. | 2,519 | $298K |
| MEDPMedpace Holdings Inc. | 619 | $297K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,070 | $289K |
| BMYBRISTOL MYERS SQUIBB CO | 3,391 | $206K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.